ConcertAI enhances CancerLinQ Suite for oncology trials
The CancerLinQ Suite uses AI to convert unstructured data into actionable insights and unifies quality governance.
Clinical Trials
Kalohexis doses first patients in 710GO Phase I trial for obesity
MSD and Adcendo sign collaboration agreement for Phase Ib trial
First participant dosed in Jade’s Phase II JUNIPER trial for IgAN
Bial concludes treatment period in Phase IIb ACTIVATE trial for PD
Lilly reports positive interim results from Heart-2 trial of VERVE-102
Caliway secures FDA clearance for CBL-514 clinical trial
Biogen and Denali report Phase IIb LUMA trial data for Parkinson’s
